{"DataElement":{"publicId":"14606486","version":"1","preferredName":"Sequencing Library End Bias Type","preferredDefinition":"The type of overabundance of transcripts seen in a sequencing library.","longName":"14606483v1.00:14606485v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"14606483","version":"1","preferredName":"Sequencing Library End Bias","preferredDefinition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.:An overabundance of sequences from the 3' end of a transcript due to methods that use poly-dT for mRNA capture or initiation of reverse transcription.","longName":"6273321v1.00:14606482v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"6273321","version":"1","preferredName":"Sequencing Library","preferredDefinition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.","longName":"C148073","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sequencing Library","conceptCode":"C148073","definition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BEC8634-0E48-602E-E053-F662850A059F","latestVersionIndicator":"Yes","beginDate":"2018-05-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-11","modifiedBy":"ONEDATA","dateModified":"2018-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14606482","version":"1","preferredName":"End Bias","preferredDefinition":"An overabundance of sequences from the 3' end of a transcript due to methods that use poly-dT for mRNA capture or initiation of reverse transcription.","longName":"C201928","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"End Bias","conceptCode":"C201928","definition":"An artifact of cDNA amplification and cloning where either the 5' or the 3' ends of transcripts are over-represented in the final sample or library.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A477D07-0ABC-5F34-E063-731AD00A96AF","latestVersionIndicator":"Yes","beginDate":"2023-11-16","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-11-16","modifiedBy":"SOKKERL","dateModified":"2023-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0A477D07-0ABD-5F34-E063-731AD00A96AF","latestVersionIndicator":"Yes","beginDate":"2023-11-16","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-11-16","modifiedBy":"SOKKERL","dateModified":"2023-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14606485","version":"1","preferredName":"End Bias Type","preferredDefinition":"An overabundance of sequences from the 3' end of a transcript due to methods that use poly-dT for mRNA capture or initiation of reverse transcription._Something distinguishable as an identifiable class based on common qualities.","longName":"14606485v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14606484","version":"1","preferredName":"End Bias Type","preferredDefinition":"An overabundance of sequences from the 3' end of a transcript due to methods that use poly-dT for mRNA capture or initiation of reverse transcription._Something distinguishable as an identifiable class based on common qualities.","longName":"14606484v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"End Bias","conceptCode":"C201928","definition":"An artifact of cDNA amplification and cloning where either the 5' or the 3' ends of transcripts are over-represented in the final sample or library.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A4798EC-7554-6391-E063-731AD00A0F31","latestVersionIndicator":"Yes","beginDate":"2023-11-16","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-11-16","modifiedBy":"SOKKERL","dateModified":"2023-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0A4798EC-7555-6391-E063-731AD00A0F31","latestVersionIndicator":"Yes","beginDate":"2023-11-16","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-11-16","modifiedBy":"SOKKERL","dateModified":"2023-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594094","version":"1","longName":"Sequencing","context":"Pediatric Cancer"},{"publicId":"13594225","version":"1","longName":"Single Cell Sequencing File","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"End_Bias","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"End Bias","url":null,"context":"Pediatric Cancer"}],"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0A479E83-611E-6472-E063-731AD00AB522","latestVersionIndicator":"Yes","beginDate":"2023-11-16","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-11-16","modifiedBy":"COLBERTM","dateModified":"2023-11-17","changeDescription":null,"administrativeNotes":"11/16/23 Created per CCDI submission template.ls","unresolvedIssues":null,"deletedIndicator":"No"}}